Application Deadline: August 1, 2021
The following is an overview of the SAEMF Emerging Infectious Disease and Preparedness Grant. For complete instructions on applying, please see the detailed instructions. For submission instructions and SAEMF policies, visit How To Apply. For answers to other common questions, visit our Grants FAQ, or email firstname.lastname@example.org.
All application components, including letters of support, must be submitted through the SAEM Foundation Grant Portal. All applications must be received by 5 pm (Central time) on their due date. No additional material (e.g. updates, publications, corrections, etc.) will be accepted after the application deadline.
Applicants must use the most current version of the National Institutes of Health (NIH) PHS 398 forms which can be downloaded at: http://grants1.nih.gov/grants/funding/phs398/phs398.html#forms. If there are questions regarding formatting, formatting which conforms to NIH guidelines will always be accepted.
The latest NIH biosketch format should be used for the applicant, mentor(s), and other key personnel. This includes a section for a personal statement. See biosketch instructions for further information.
Font type and size for the application should be Arial 11 point, including literature cited. Single line spacing is acceptable. Figures, charts, tables, and legends or captions may be in smaller size font but must be clear and legible.
Blank/plain paper can be used as needed in lieu of continuation pages when no form is specified to be used. The margins must be no less than the following dimensions: top: 0.8, bottom: 0.5, left: 0.5, right: 0.5.
Submission must be no longer than 5 pages in length (excluding references). All proposals must include specific aims, background/significance, preliminary work (if applicable), and approach.
PURPOSE OF THE AWARD
The purpose of this award is to support emergency care research related to emerging infectious disease (e.g. influenza, COVID-19, or other infections--this award is not limited to specific conditions). This award seeks to support an ambitious program of acute care science in emerging infectious disease that may include diagnostics, patient and provider safety, intervention/therapeutics, disaster preparedness, or other relevant topic areas. Projects leveraging innovative methodological designs, such as implementation trials, computational methods and data science are encouraged. While the focus is on self-limited research projects that are impactful in the current or future practice of emergency medicine and can be completed in a one-year time frame, the funds apportioned for this award are provided with the hope for investigators to propose an ambitious program of research that can lead to a sustained program of externally supported funded research. The goals of the grant align with mission of the SAEMF to improve emergency patient care through supporting the development of innovative researchers, expert educators and future academic emergency medicine leaders.
An applicant for the SAEMF Emerging Infectious Disease and Preparedness Grant must:
- Be a member of SAEM in good standing at application deadline and during the entire award period.
- Have an advanced/doctoral or terminal educational degree (e.g., MD, DO, PhD, PharmD, DSc or equivalent).
- Hold a faculty university appointment with a department or division of emergency medicine or pediatric emergency medicine at the start of the award period. Emergency medicine residents or fellows in their final year of training may apply as long as they will hold a university faculty appointment at the start of the award period. The applicant may work as a clinician at an institution other than the host institution or the institution at which the project will be conducted.
- Not have received a similar grant for the same purpose as the SAEMF proposal (no overlapping funds).
THE FINANCIAL AWARD
Applicants may request up to $100,000 for a one-year project.
Funds from the grant may be used for direct costs related to the project (e.g., laboratory supplies, research assistant or data analyst time, data purchase, research animals, clinical research supplies, etc.). A maximum of $500 is allowed for travel to conferences to present research findings. Travel expenses must be consistent with the SAEMF travel policy. Funds from the grant may be used for faculty salary support. Indirect costs (i.e., facilities and administrative costs) are not supported by this grant. Any residual funds will be returned to SAEMF at the end of the award period.
Costs included in the grant budget should not exceed $100,000 over one year. However, in addition to the funds from SAEMF, the budget justification should reflect all pending and active sources of funding relevant to the project. The submission of detailed budgets and budget justifications for the use of funds for the grant from SAEMF and additional funds available to support the goals of the award from all other sources are required as part of the application and again for award recipients during the reporting period of the award.
Failure to meet the award guidelines or inability of the awardee to complete the term of the award shall result in the need to return residual funds to SAEMF.
For projects requiring the host institution’s Institutional Review Board (IRB) or equivalent approval, funds will not be dispersed until IRB approval is obtained. Award extensions may be made at the discretion of the Grants Committee on a case-by-case basis.
DURATION OF THE AWARD
The award is for one year (grant period July 1, 2022 – June 30, 2023).
A progress report is due on December 1 during the grant period. The final project and financial report are due August 1 at the end of the grant period. The progress report template is available at Post Award.
Report to SAEMF within 1 year of close of grant period. In addition, successful project completion will be demonstrated by at least one of the following: (1) a research abstract submitted to the SAEM or another national meeting relevant to the project topic; or (2) a manuscript submitted to a peer-reviewed publication relevant to the project topic.
GRANT REVIEW PROCESS
The Grants Committee is responsible for the review of all applications and will make recommendations to the SAEMF Board of Trustees regarding recipients. A scoring system considering the overall impact and association with the mission, feasibility, approach and investigator will be assessed. It is expected that the work will be completed at the close of the one-year grant period. The grant will only be awarded if the Grants Committee and SAEMF deems that an applicant worthy of receiving this award can be selected.
Please contact email@example.com with any questions.
Updated March 1, 2021
POLICIES GOVERNING THE USE OF HUMANS AND ANIMALS
If human or animal experimentation is to be performed during the period of the award, the department and institution to be used as the training site must affirm that: (1) investigations involving human subjects proposed and subsequently carried out in the application have been endorsed and approved by the IRB, or other clearly designated appropriate body, at the study site; (2) any research involving human subjects will conform ethically with the guidelines prescribed by the NIH; and (3) research involving animals will conform with the current "Guide for the Care and Use of Laboratory Animals", NIH publication, of the Department of Health and Human Services/United States Public Health Service (DHHS/USPHS), and has been approved by the Animal Care and Use Committee at the study site.
INVESTIGATORY FINANCIAL DISCLOSURE POLICY/OBJECTIVITY IN RESEARCH
Applicants and institutions are required by SAEMF to comply with the USPHS regulations, Final Rule, 42 CFR Part 50, Subpart F: Responsibility of Applicants for Promoting Objectivity in Research. The applicant’s and mentor’s institution or host institution official’s signature on the signature page of the application indicates compliance that an institutional administrative process is in effect to identify and resolve conflicting financial interests of the type described in Subpart 50.604(a) with respect to all projects for which funding is sought from SAEMF.
PATENT, INTELLECTUAL PROPERTY, AND TECHNOLOGY TRANSFER POLICY
All inventions discovered or arising out of research supported in whole or in part by SAEMF, which may be used in emergency medicine research, teaching, or practice, shall be reported within one (1) year to SAEMF. "Invention" is any discovery, material, method, process, product, program, software or app (mobile, application software, web application, etc) of use, whether or not patented or patentable or copyrighted or copyrightable, that has application of value such that its use, licensing, lease, or sale can generate revenue. If the institution receiving or disbursing SAEMF funds that supported the invention has an established and applicable patent, intellectual property, or technology transfer policy/procedure for administering inventions, SAEMF will defer to that policy. If the institution has no established and applicable patent, intellectual property, or technology transfer policy/procedure for administering inventions, SAEMF shall have the right to determine the disposition of invention rights. In such cases, SAEMF may:
- Decide that patent and copyright should be or not be filed;
- Release the invention to the inventor(s) or inventor's designee;
- Submit the invention to a qualified organization for administration and licensing;
- Determine by negotiation the fair share of royalty income to be paid to the inventor(s);
- License or make other arrangements for the application and use of the invention on an exclusive or non-exclusive, royalty, or royalty-free basis.